about
A mathematical analysis of SELEXNMR structures of double loops of an RNA aptamer against mammalian initiation factor 4ANeutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinaseIn Vitro Selection of Cancer Cell-Specific Molecular Recognition Elements from Amino Acid LibrariesAdvanced sequencing technologies: methods and goalsDifferential SELEX in human glioma cell linesSearch for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications.SELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of reverse transcription.Selective delivery of therapeutic agents for the diagnosis and treatment of cancer.Multitasking by multivalent circular DNA aptamers.Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cellsUsing DNA aptamer probe for immunostaining of cancer frozen tissues.Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissues.Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discoveryAdvances in the development of therapeutic nucleic acids against cervical cancer.Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells.The Optimization and Characterization of an RNA-Cleaving Fluorogenic DNAzyme Probe for MDA-MB-231 Cell Detection.Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.Probing the structure of DNA aptamers with a classic heterocycle.Aptamer-based capture molecules as a novel coating strategy to promote cell adhesion.Combination of an aptamer probe to CD4 and antibodies for multicolored cell phenotyping.Aptamer-conjugated nanoparticles for cancer cell detection.Aptamer redesigned tRNA is nonfunctional and degraded in cells.The application of aptamer 5TR1 in triple negative breast cancer target therapy.Engineered Aptamers to Probe Molecular Interactions on the Cell Surface.
P2860
Q24643926-0E38508A-D3D6-407A-BDEA-35B054F65D94Q24802274-B44EA937-6739-416E-9DCB-743AA55B2AE8Q24803451-B0378B37-80D0-4F5B-A825-A689DFD0FC35Q26782129-6BE66B51-034E-4647-A095-B61E77813D83Q28261786-C9394015-F980-4939-81D3-C030B4CC4B53Q28750173-E9F33868-DACC-44C6-8098-5DC9356CD4B1Q31059425-B5ADE166-FCE6-4408-A28C-66EADA9558F1Q33206025-F1812FC8-AA3B-45FA-A80B-022EAEC78414Q33230098-01081C79-A863-4AE5-AC65-A215AC47ACF4Q33234113-BD067684-26E1-448F-93FC-5782FE93D5B8Q34247575-2468FBCD-D4C9-4551-BBA3-4F37152275D1Q35054102-C38CB448-7496-41EE-803A-3B3BA3927C40Q35173834-1FE34419-C88C-4544-A1F6-C2F5E9545238Q35600644-CA820251-B6B5-43A5-A59C-D5980C2AE2CBQ35842608-65E9C566-C22C-4C35-AE0F-1B75DF7D7615Q37149264-3194907B-88FF-4CB0-B98F-F0A7B07231B9Q37732846-EC692456-1198-40D2-AA79-D1773E04A067Q38272165-93CA5871-3B94-42CF-96A0-55C939661FB4Q38296375-B7BD9222-65AC-4EF3-BB78-D8C47274704BQ38320377-FADC071A-F1CC-491C-9BDC-DC7E0CC4BD72Q38340719-C1D85B98-F0D3-4088-A034-69083FC1D11BQ39610225-6B8E89BE-330A-4BB5-9066-98CBBA3C9820Q42177584-1EC36824-06D7-4C70-9A31-103C0C1F2EBBQ48187126-EB78FAF2-7E5E-47BE-B977-60B7B8E24AE8Q53092802-AEFC3EAC-686B-4BFE-823E-FC6CCF56C9D4
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nucleic acid aptamers in cancer medicine.
@ast
Nucleic acid aptamers in cancer medicine.
@en
type
label
Nucleic acid aptamers in cancer medicine.
@ast
Nucleic acid aptamers in cancer medicine.
@en
prefLabel
Nucleic acid aptamers in cancer medicine.
@ast
Nucleic acid aptamers in cancer medicine.
@en
P2093
P2860
P1433
P1476
Nucleic acid aptamers in cancer medicine.
@en
P2093
Bertrand Tavitian
Domenico Libri
Laura Cerchia
Vittorio de Franciscis
P2860
P356
10.1016/S0014-5793(02)03275-1
P407
P577
2002-09-01T00:00:00Z